EMA — authorised 26 September 2019
- Marketing authorisation holder: Mylan S.A.S
- Status: approved
EMA authorised Exjade on 26 September 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 26 September 2019.
Mylan S.A.S holds the EU marketing authorisation.